Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3216293rdf:typepubmed:Citationlld:pubmed
pubmed-article:3216293lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0439603lld:lifeskim
pubmed-article:3216293lifeskim:mentionsumls-concept:C0449435lld:lifeskim
pubmed-article:3216293pubmed:dateCreated1989-3-9lld:pubmed
pubmed-article:3216293pubmed:abstractTextHLA-A, -B, -C, -DR, and -DQ antigen phenotypes were determined in 266 Caucasian homosexual men, 90 of whom were HIV-1 seronegative, 94 HIV-1 seropositive AIDS-free, and 82 with a diagnosis of AIDS [36 with Kaposi's sarcoma (KS), 34 with opportunistic infection (OI), and 12 with KS and OI]. No significant differences in HLA-A or -B antigen frequencies were found in any comparisons of these groups. However, in comparisons of seropositive AIDS-free men with the AIDS groups, HLA-Cw7 was increased in frequency in OI and HLA-DR1, -DRw14, and -DQw1 in KS. HLA-DR3 and -DQw3 frequencies were decreased in KS, and DRw53 was decreased in OI. In a cohort of 102 HIV seropositive individuals that were followed for a mean of 43 months, AIDS developed in HLA-DR1 positive men more frequently than in individuals with other HLA-DR phenotypes (p = 0.02). These results demonstrate probable genetic differences between individuals developing KS and OI and indicate that the HLA-DR1 phenotype is a risk factor in disease progression in human immunodeficiency virus (HIV)-infected individuals.lld:pubmed
pubmed-article:3216293pubmed:languageenglld:pubmed
pubmed-article:3216293pubmed:citationSubsetIMlld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3216293pubmed:statusMEDLINElld:pubmed
pubmed-article:3216293pubmed:authorpubmed-author:PILZCClld:pubmed
pubmed-article:3216293pubmed:authorpubmed-author:BlattnerW AWAlld:pubmed
pubmed-article:3216293pubmed:authorpubmed-author:MurrayCClld:pubmed
pubmed-article:3216293pubmed:authorpubmed-author:YarchoanRRlld:pubmed
pubmed-article:3216293pubmed:authorpubmed-author:GoedertJ JJJlld:pubmed
pubmed-article:3216293pubmed:ownerNLMlld:pubmed
pubmed-article:3216293pubmed:authorsCompleteYlld:pubmed
pubmed-article:3216293pubmed:pagination13-7lld:pubmed
pubmed-article:3216293pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:meshHeadingpubmed-meshheading:3216293-...lld:pubmed
pubmed-article:3216293pubmed:articleTitleHLA antigen frequencies in HIV-1 seropositive disease-free individuals and patients with AIDS.lld:pubmed
pubmed-article:3216293pubmed:affiliationLaboratory of Human Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892.lld:pubmed
pubmed-article:3216293pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3216293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3216293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3216293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3216293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3216293lld:pubmed